PRAC update on ongoing evaluation of myocarditis and pericarditis with COVID-19 vaccines

The PRAC requires further analysis of cases of myocarditis and/or pericarditis reported with all COVID-19 vaccines and is requesting additional data from manufacturers and is encouraging all healthcare professionals to report any cases.

European Medicines Agency